Santen Pharmaceutical Co., Ltd.
4536Drug Manufacturers - General
¥1,770.50+0.97%As of Oct 29vs prior close
- Market cap
- $3.6B
- P/E (TTM)
- 14.9×
- P/E (FY1)
- 14.7×
- From 52W high
- −20.82%
- EPS (LTM)
- ¥118.82
- Revenue (LTM)
- ¥291.8B
- Net margin
- 13.26%
Nomior Score
56
Steady ProfileSpeculativeTop 34% of the scored universe
Growth35
Quality58
Value56
Momentum59
Resilience65
Growth
+1.48%revenue a year over 3 fiscal years
YE23 ¥279BLTM ¥291.8B
Connections
Revenue to profitYE26
13% of revenue became net profit, up 1 pt on a year.